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their diagnosis a great challenge for clinicians. We describe a 78-year-old man with swelling
and pain of right knee for 6 months. The patient was empirically treated for tuberculosis
because positive enzyme-linked immunospot assay for interferon-g of blood was reported at
2 days after aspiration of synovial fluid, which was negative for acid-fast stain but subse-
quently grew Mycobacterium tuberculosis 6 weeks later. He recovered uneventfully with
1-year antituberculous combination therapy.
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398 C.-K. Tan et al.Introduction
Musculoskeletal tuberculosis (TB) accounts for 1e3% of all
forms of TB and approximately 10% of cases with extrap-
ulmonary TB.1,2 The definite diagnosis requires the identi-
fication of Mycobacterium tuberculosis from the synovial
fluid or biopsied tissue; however, only 60e80% of cases had
the positive cultures of M tuberculosis.3 An enzyme-linked
immunospot (ELISPOT) assay was developed to detect
interferon-g produced by activated T cell after exposure to
two specific antigens of M tuberculosis, that is, early
secretory antigenic target 6 and culture filtrate protein
10, which are present in M tuberculosis but absent in
Mycobacterium bovis bacilli CalmetteeGuerin and most
environmental nontuberculous mycobacteria.4 Previous
studies showed that ELISPOT assay would be useful for theFigure 1. Short-tau inversion recovery (STIR) magnetic resona
saturation (B and D) of the right knee showing effusion in suprapa
(white arrow); some foci of abnormal signal intensity and enhance
pyomyositis with heterogeneous content in the popliteus muscle (bdiagnosis of extrapulmonary TB in both immunocompetent
and immunocompromised patients.4e10 We, hereby,
demonstrate the usefulness of ELISPOT assay in one patient
with tuberculous arthritis and pyomyositis.
Case report
A 78-year-old HIV-negative man was referred to our hospital
because of swelling and pain of the right knee for 6 months.
On admission, fever up to 39C was noted. Physical exam-
inations were unremarkable except for a swollen right knee
with local heat and tenderness. The range of motion of the
right knee was moderately limited in all directions. Labo-
ratory examinations revealed a white blood cell count of
4,510/mm3 and C-reactive protein of 4.75 mg/dL (normal
range, <0.8 mg/dL). Magnetic resonance imaging of thence images (A and C) and contrast-enhanced T1WI with fat
tellar fossa with diffuse synovial thickening and enhancement
ment in the subchondral bone marrow (arrow head); and large
lack arrow).
ELISPOT for tuberculous arthritis 399right knee showed moderate amount of effusion and
marked synovial proliferation and enhancement in the right
suprapatellar bursa and knee joint with some debris and
multifocal subchondral marrow edema/hyperemia (Fig. 1).
Aspiration of joint effusion yielded 3 mL of serosanguinous
fluid. No crystal was found on microscopic examination.
Synovial fluid analysis revealed a white blood cell count of
800/mm3. The Gram stain and acid-fast stain of the aspi-
rated synovial fluid were negative, and the routine aerobic
and anaerobic bacterial cultures were also negative.
Chronic monoarthritis and myositis were suspected. The
autoantibody screening assays, including rheumatoid
factor and antinuclear antibody, were negative. ELISPOT
assay was performed on peripheral blood showing 102
early secretory antigenic target 6 and 84 culture filtrate
protein 10 interferon-g spot-forming cells per 250,000
peripheral blood mononuclear cells. More than five spot-
forming cells per 250,000 peripheral blood mononuclear
cells is regarded as a positive result by the manufacturer.
The ELISPOT assay of the patient’s blood specimen
revealed a positive result 2 days later. Six weeks later, the
synovial fluid grew M tuberculosis, and the diagnosis of TB
arthritis and pyomyositis was confirmed. The patient
received anti-TB treatment for 1 year and remained
uneventful.
Discussion
The clinical manifestations of extrapulmonary TB were
protean and included meningitis, genitourinary infection,
pericarditis, lymphadenitis, pleurisy, peritonitis, musculo-
skeletal infection, and cutaneous TB. The prevalence of
extrapulmonary TB ranges from 15% to 25%, according
to the estimation of the World Health Organization
surveillance study.11 Furthermore, about 3% of patients
with TB have musculoskeletal involvement, which mostly
causes spondylitis, osteomyelitis, or arthritis.12 In addi-
tion, tuberculous myositis has rarely been described in
the medical literature, and its manifestations may mimic
malignant or other inflammatory diseases, leading to
misdiagnosis.13 Although the mechanism of how
M tuberculosis reaches the musculoskeletal system is not
fully understood, hematogenous dissemination and direct
inoculation have been suggested. However, like our case,
there is no evidence of concurrent active or arrested
tuberculous foci in any location other than the musculo-
skeletal system.
Tuberculous arthritis and pyomyositis usually present in
a slow indolent manner with nonspecific clinical presenta-
tions; therefore, the diagnosis of tuberculous arthritis is
often difficult and even delayed. The definite diagnosis
usually requires histological and microbiological confirma-
tions. The microbiological gold standard is too insensitive
and time consuming to be used along for making the diag-
nosis. Either the solid media-based techniques, such as
LowenstineJensen and Middlebrook 7H10/11, or liquid
media-based methods, such as BACTEC (BD Diganostics,
Sparks, MD, USA) and MGIT (BD Diagnostics) take weeks to
complete the test.14,15 In contrast, several studies report
that the ELISPOT assay is a rapid and adjunct test for
diagnosing extrapulmonary TB,5 including TB pleurisy,6lymphadenitis,7 intestinal TB,8 meningitis,9 and pericar-
ditis.10 Moreover, Liao et al.16 showed that the sensitivity
of ELISPOT assay for the diagnosis of extrapulmonary TB
could range from 100% for tuberculous meningitis, tuber-
culous pericarditis, and intestinal TB; 95% for lymphade-
nitis; to 42.9% for tuberculous peritonitis. This case further
illustrates the potential advantages and usefulness of
measuring mycobacterium-specific immune response by the
ELISPOT assay for the rapid diagnosis of tuberculous
arthritis and pyomyositis; particularly, the microbiological
culture results are still not available.
In conclusion, we demonstrate the diagnostic utility of
ELISPOT assay in a patient with TB arthritis and pyomyosi-
tis; however, further large-scale studies are needed to
clarify its diagnostic value in this rare disease category.Acknowledgment
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